|Characterisation and manipulation of docetaxel resistant prostate cancer cell lines|
AJ O'Neill, M Prencipe, C Dowling, Y Fan, L Mulrane, WM Gallagher, ...
Molecular cancer 10 (1), 1-13, 2011
|Core fucosylation and α2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia|
R Saldova, Y Fan, JM Fitzpatrick, RWG Watson, PM Rudd
Glycobiology 21 (2), 195-205, 2011
|Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer|
M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ...
Scientific reports 6 (1), 1-13, 2016
|2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer|
JC Byrne, MR Downes, N O’Donoghue, C O’Keane, A O’Neill, Y Fan, ...
Journal of proteome research 8 (2), 942-957, 2009
|Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer|
Y Fan, TB Murphy, JC Byrne, L Brennan, JM Fitzpatrick, RWG Watson
Journal of proteome research 10 (3), 1361-1373, 2011
|MetSizeR: selecting the optimal sample size for metabolomic studies using an analysis based approach|
G Nyamundanda, IC Gormley, Y Fan, WM Gallagher, L Brennan
BMC bioinformatics 14 (1), 1-8, 2013
|Therapeutic rationale to target highly expressed CDK7 conferring poor outcomes in triple-negative breast cancer|
B Li, TN Chonghaile, Y Fan, SF Madden, R Klinger, AE O'Connor, ...
Cancer research 77 (14), 3834-3845, 2017
|Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4+ 3 as high or intermediate grade|
DM Fanning, E Kay, Y Fan, JM Fitzpatrick, RWG Watson
BJU international 105 (5), 631-635, 2010
|Investigation of molecular alterations of AKT‐3 in triple‐negative breast cancer|
G O'Hurley, E Daly, A O'Grady, R Cummins, C Quinn, L Flanagan, ...
Histopathology 64 (5), 660-670, 2014
|The impact of high-dose statin therapy on transendothelial neutrophil migration and serum cholesterol levels in healthy male volunteers|
A Kinsella, A Raza, S Kennedy, Y Fan, AE Wood, RW Watson
European journal of clinical pharmacology 67 (11), 1103-1108, 2011
|Evaluation of prediction models for the staging of prostate cancer|
S Boyce, Y Fan, RW Watson, TB Murphy
BMC medical informatics and decision making 13 (1), 1-10, 2013
|External validation of the 2007 and 2001 Partin tables in Irish prostate cancer patients|
DM Fanning, Y Fan, JM Fitzpatrick, RWG Watson
Urologia internationalis 84 (2), 174-179, 2010
|digeR: a graphical user interface R package for analyzing 2D-DIGE data|
Y Fan, TB Murphy, RWG Watson
Bioinformatics 25 (22), 3033-3034, 2009
|Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer|
X Lv, M He, Y Zhao, L Zhang, W Zhu, L Jiang, Y Yan, Y Fan, H Zhao, ...
Cancer cell international 19 (1), 1-12, 2019
|Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post‐surgery|
KJ Breen, A O'Neill, L Murphy, Y Fan, S Boyce, N Fitzgerald, E Dorris, ...
The Prostate 77 (12), 1288-1300, 2017
|Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node‐negative breast cancer patients|
F Lanigan, GL Brien, Y Fan, SF Madden, E Jerman, A Maratha, F Aloraifi, ...
The FEBS journal 282 (18), 3455-3473, 2015
|SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway|
W Zhu, J Niu, M He, L Zhang, X Lv, F Liu, L Jiang, J Zhang, Z Yu, L Zhao, ...
Journal of translational medicine 17 (1), 1-15, 2019
|15th international thyroid congress program and meeting abstracts|
RN Miguel, J Sanders, J Furmaniak, BR Smith, C Li, F Menconi, R Osman, ...
Thyroid 25 (S1), P-1-A-337, 2015
|The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancer|
SF Oon, DM Fanning, Y Fan, S Boyce, TB Murphy, JM Fitzpatrick, ...
The Prostate 72 (14), 1523-1531, 2012
|Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer|
N Elster, S Toomey, Y Fan, M Cremona, C Morgan, K Weiner Gorzel, ...
Therapeutic advances in medical oncology 10, 1758835918778297, 2018